v. 34: no. 1 (2008: Jan. 1)

v. 34: no. 2 (2008: Feb. 1)

v. 34: no. 3 (2008: March)

v. 34: no. 4 (2008: April)

v. 34: no. 5 (2008: May)

v. 34: no. 6 (2008: June)

v. 34: no. 7 (2008: July)

v. 34: no. 8 (2008: Aug.)

v. 34: no. 9 (2008: Sept.)

v. 34: no. 10 (2008: Oct.)

v. 34: no. 11 (2008: Nov.)

v. 34: no. 12 (2008: Dec.)

Vol. 34: Supplement 1, Jan. 2008 - Guideline for investigation of suspected transfusion transmitted bacterial contamination

Vol. 34: Supplement 2, Mar. 2008 - Final report of outcomes from the National Consensus Conference for vaccine-preventable diseases in Canada

ACS-1. Advisory Committee Statement - Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine

ACS-2. Advisory Committee Statement - Statement on hepatitis vaccines for travellers

ACS-3. Statement on influenza vaccination for the 2008-2009 season

ACS-4. Statement on protection against Japanese encephalitis

ACS-5. Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users

ACS-6. Updated recommendations on interferon gamma release assays for latent tuberculosis infection